AMP-activated protein kinase confers protection against TNF-α-induced cardiac cell death

Cardiovascular Research

Volumn 84, Issue 1, 2009, Pages 42-53

  Kewalramani, Girish ^a   Puthanveetil, Prasanth ^a   Wang, Fang ^a   Kim, Min Suk ^a   Deppe, Sylvia ^a   Abrahani, Ashraf ^a   Luciani, Dan S ^a   Johnson, James D ^a   Rodrigues, Brian ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

AMPK; Apoptosis; Cardiomyocyte; Dexamethasone; Metformin

Indexed keywords

CASPASE 3; CYTOCHROME C; DEXAMETHASONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN; PROTEIN BAD; PROTEIN BCL XL; TUMOR NECROSIS FACTOR ALPHA; BAD PROTEIN, RAT; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE I; CAMK1 PROTEIN, RAT; SCATTER FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; ANIMAL; DRUG EFFECT; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SECRETION; WISTAR RAT;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 1; CASPASE 3; CYTOCHROMES C; DEXAMETHASONE; MALE; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MET; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70449707334     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp166     Document Type: Article

References (60)

1. Levine SJ. Molecular mechanisms of soluble cytokine receptor generation. J Biol Chem 2008;283:14177-14181.
2. Kirkegaard T, Pedersen G, Saermark T, Brynskov J. Tumour necrosis factor-alpha converting enzyme (TACE) activity in human colonic epithelial cells. Clin Exp Immunol 2004;135:146-153.
3. Marques LJ, Zheng L, Poulakis N, Guzman J, Costabel U. Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages. Am J Respir Crit Care Med 1999;159:508-511.
4. Torrado E, Adusumilli S, Fraga AG, Small PL, Castro AG, Pedrosa J. Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection. Infect Immun 2007;75:3979-3988.
5. Ryffel B, Brockhaus M, Durmuller U, Gudat F. Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha. Am J Pathol 1991;139:7-15.
6. Ranta V, Orpana A, Carpen O, Turpeinen U, Ylikorkala O, Viinikka L. Human vascular endothelial cells produce tumor necrosis factor-alpha in response to proinflammatory cytokine stimulation. Crit Care Med 1999;27:2184-2187.
7. McLachlan JB, Hart JP, Pizzo SV, Shelburne CP, Staats HF, Gunn MD et al. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 2003;4:1199-1205.
8. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91.
9. Saliba E, Henrot A. Inflammatory mediators and neonatal brain damage. Biol Neonate 2001;79:224-227.
10. Benderdour M, Hess K, Dzondo-Gadet M, Nabet P, Belleville F, Dousset B. Boron modulates extracellular matrix and TNF alpha synthesis in human fibroblasts. Biochem Biophys Res Commun 1998;246:746-751.
11. Grandel U, Fink L, Blum A, Heep M, Buerke M, Kraemer HJ et al. Endotoxin-induced myocardial tumor necrosis factor-alpha synthesis depresses contractility of isolated rat hearts: evidence for a role of sphin-gosine and cyclooxygenase-2-derived thromboxane production. Circulation 2000;102:2758-2764.
12. Liu ZG, Han J. Cellular responses to tumor necrosis factor. Curr Issues Mol Biol 2001;3:79-90.
13. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003;114:181-190.
14. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ et al. Tw o CD95 (APO-1/Fas) signaling pathways. EMBO J 1998;17:1675-1687.
15. Aikawa R, Nitta-Komatsubara Y, Kudoh S, Takano H, Nagai T, Yazaki Y et al. Reactive oxygen species induce cardiomyocyte apoptosis partly through TNF-alpha. Cytokine 2002;18:179-183.
16. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific over-expression of tumor necrosis factor-alpha. Circ Res 1997;81:627-635.
17. Engel D, Peshock R, Armstong RC, Sivasubramanian N, Mann DL. Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression. Am J Physiol Heart Circ Physiol 2004;287:H1303-H1311.
18. Zhang L, Peppel K, Sivashanmugam P, Orman ES, Brian L, Exum ST et al. Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis. Arterioscler Thromb Vasc Biol 2007;27: 1087-1094.
19. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-150.
20. Schulz R, Aker S, Belosjorow S, Heusch G. TNFalpha in ischemia/reperfu-sion injury and heart failure. Basic Res Cardiol 2004;99:8-11.
21. Arbustini E, Grasso M, Diegoli M, Bramerio M, Foglieni AS, Albertario M et al. Expression of tumor necrosis factor in human acute cardiac rejection. An immunohistochemical and immunoblotting study. Am J Pathol 1991; 139:709-715.
22. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 1996;98:2854-2865.
23. Song W, Lu X, Feng Q. Tumor necrosis factor-alpha induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes. Cardi-ovasc Res 2000;45:595-602.
24. Grethe S, Porn-Ares MI. p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK1/2 survival pathway in TNF-alpha induced endothelial apoptosis. Cell Signal 2006;18:531-540.
25. van Empel VP, Bertrand AT, HofstraL,Crijns HJ, DoevendansPA,DeWindtLJ. Myocyte apoptosis in heart failure. Cardiovasc Res 2005;67:21-29.
26. Hardie DG, Hawley SA. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 2001;23:1112-1119.
27. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 2005;280:29060-29066.
28. Blazquez C, Geelen MJ, Velasco G, Guzman M. The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes. FEBS Lett 2001;489:149-153.
29. Ido Y, Carling D, Ruderman N. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes 2002;51:159-167.
30. Hwang JT, Kwon DY, Park OJ, Kim MS. Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells. Genes Nutr 2008;2:323-326.
31. Rodrigues B, Cam MC, Jian K, Lim F, Sambandam N, Shepherd G. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity. Diabetes 1997;46:1346-1353.
32. Kewalramani G, Puthanveetil P, Kim MS, Wang F, Lee V, Hau N et al. Acute dexamethasone-induced increase in cardiac lipoprotein lipase requires activation of both Akt and stress kinases. Am J Physiol Endocrinol Metab 2008;295:E137-E147.
33. An D, Kewalramani G, Chan JK, Qi D, Ghosh S, Pulinilkunnil T et al. Met-formin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3. Diabetologia 2006;49:2174-2184.
34. Xu YJ, Shao Q, Dhalla NS. Fura-2 fluorescent technique for the assessment of Ca2+ homeostasis in cardiomyocytes. Mol Cell Biochem 1997; 172:149-157.
35. An D, Pulinilkunnil T, Qi D, Ghosh S, Abrahani A, Rodrigues B. The metabolic 'switch' AMPK regulates cardiac heparin-releasable lipoprotein lipase. Am J Physiol Endocrinol Metab 2005;288:E246-E253.
36. Qi D, Pulinilkunnil T, An D, Ghosh S, Abrahani A, Pospisilik JA et al. Single-dose dexamethasone induces whole-body insulin resistance and alters both cardiac fatty acid and carbohydrate metabolism. Diabetes 2004; 53:1790-1797.
37. Qi D, An D, Kewalramani G, Qi Y, Pulinilkunnil T, Abrahani A et al. Altered cardiac fatty acid composition and utilization following dexamethasone-induced insulin resistance. Am J Physiol Endocrinol Metab 2006;291: E420-E427.
38. Jensen TE, Rose AJ, Jorgensen SB, Brandt N, Schjerling P, Wojtaszewski JF et al. Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction. Am J Physiol Endocrinol Metab 2007;292: E1308-E1317.
39. Kim A, Li J, Hu J, Edelman AM, Young LH. Ca2+/Calmodulin-dependant kinase kinase beta (CaMKKb) contribuites to AMPK activation in the heart during hypoxia (Abstract). Circulation 2007;116:II 34.
40. Lee SM, Yune TY, Kim SJ, Kim YC, Oh YJ, Markelonis GJ et al. Minocycline inhibits apoptotic cell death via attenuation of TNF-alpha expression following iNOS/NO induction by lipopolysaccharide in neuron/glia co-cultures. J Neurochem 2004;91:568-578.
41. Stahn C, Buttgereit F. Genomic and nongenomic effects of glucocorti-coids. Nat Clin Pract Rheumatol 2008;4:525-533.
42. Song IH, Buttgereit F. Non-genomic glucocorticoid effects to provide the basis for new drug developments. Mol Cell Endocrinol 2006;246:142-146.
43. Stahmann N, Woods A, Carling D, Heller R. Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca2+/calmodulin-dependent protein kinase kinase beta. Mol Cell Biol 2006;26:5933-5945.
44. Haller J, Mikics E, Makara GB. The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings. Front Neuroendocrinol 2008;29:273-291.
45. Ito Y, Matsuura H, Ueba Y, Fukuzaki H. The effects of large doses of dexa-methasone on myocardial contractility and calcium metabolism in experimental myocardial infarction. Adv Myocardiol 1980;2:457-464.
46. WhitehurstRM Jr, ZhangM,Bhattacharjee A,Li M. Dexamethasone-induced hypertrophy in rat neonatal cardiac myocytes involves an elevated L-type Ca(2+) current. J Mol Cell Cardiol 1999;31:1551-1558.
47. Buttgereit F, Scheffold A. Rapid glucocorticoid effects on immune cells. Steroids 2002;67:529-534.
48. Krown KA, Yasui K, Brooker MJ, Dubin AE, Nguyen C, Harris GL et al. TNF alpha receptor expression in rat cardiac myocytes: TNF alpha inhibition of L-type Ca2+ current and Ca2+ transients. FEBS Lett 1995;376:24-30.
49. Bajaj G, Sharma RK. TNF-alpha-mediated cardiomyocyte apoptosis involves caspase-12 and calpain. Biochem Biophys Res Commun 2006; 345:1558-1564.
50. Zhao X, Bausano B, Pike BR, Newcomb-Fernandez JK, Wang KK, Shohami E et al. TNF-alpha stimulates caspase-3 activation and apoptotic cell death in primary septo-hippocampal cultures. J Neurosci Res 2001;64:121-131.
51. Kim JE, Ahn MW, Baek SH, Lee IK, Kim YW, Kim JY et al. AMPK activator, AICAR, inhibits palmitate-induced apoptosis in osteoblast. Bone 2008;43: 394-404.
52. Calvert JW, Gundewar S, Jha S, Greer JJ, Bestermann WH, Tian R et al. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes 2008;57: 696-705.
53. Gundewar S, Calvert JW, Jha S, Toedt-Pingel I, Ji SY, Nunez D et al. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ Res 2009;104: 403-411.
54. Ohi N, Nishikawa Y, Tokairin T, Yamamoto Y, Doi Y, Omori Yet al. Maintenance of Bad phosphorylation prevents apoptosis of rat hepatic sinusoidal endothelial cells in vitro and in vivo. Am J Pathol 2006;168:1097-1106.
55. Steenbergen C, Afshari CA, Petranka JG, Collins J, Martin K, Bennett L et al. Alterations in apoptotic signaling in human idiopathic cardiomyo-pathic hearts in failure. Am J Physiol Heart Circ Physiol 2003;284: H268-H276.
56. Ray RM, Bhattacharya S, Johnson LR. Protein phosphatase 2A regulates apoptosis in intestinal epithelial cells. J Biol Chem 2005;280: 31091-31100.
57. Ing DJ, Zang J, Dzau VJ, Webster KA, Bishropic NH. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circ Res 1999;84:21-33.
58. Henaff M, Hatem SN, Mercadier JJ. Low catecholamine concentrations protect adult rat ventricular cardiomyocytes against apoptosis through cAMP-dependant extracellular signal-regulated kinase activation. Mol Pharmacol 2000;58:1546-1553.
59. Schreyer SA, Chua SC Jr, LeBoeuf RC. Obesity and diabetes in TNF-alpha receptor-deficient mice. J Clin Invest 1998;102:402-411.
60. Schulz R. TNFalpha in myocardial ischemia/reperfusion: damage vs. protection. J Mol Cell Cardiol 2008;45:712-714.